Blake Insomnia Therapeutics, Inc., formerly Book It Local, Inc., incorporated on August 11, 2012, is a pharmaceutical company, which is focused on improving nighttime and daytime quality of life for people with insomnia. The Company’s Zleepax is a sleep aid with beta blockers as an active agent. It is focused on stress-related insomnia. Zleepax employs beta blockers to disrupt the circle of stress leading to insomnia. The Company is raising capital to finance Phase II clinical testing of Zleepax. It is a development-stage company.
The Company’s ZLX-1, a Zleepax candidate, acts by diminishing the physical symptoms of stress that keep people awake at night. It had demonstrated efficacy without causing side effects. As of August 31, 2015, the Company had not generated any revenues.
|Market Cap (Mil.)||$37.92|
|Shares Outstanding (Mil.)||31.60|